Sphingolipid Analysis in Clinical Research

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2024 Oct 1

PMID 39354312

Authors

Jeongah Oh

Bo Burla

Sneha Muralidharan

Markus R Wenk

Federico Torta

Affiliations

Soon will be listed here.

Abstract

Sphingolipids are the most diverse class of lipids due to the numerous variations in their structural components. This diversity is also reflected in their extremely different functions. Sphingolipids are not only constituents of cell membranes but have emerged as key signaling molecules involved in a variety of cellular functions, such as cell growth and differentiation, proliferation and apoptotic cell death. Lipidomic analyses in clinical research have identified pathways and products of sphingolipid metabolism that are altered in several human pathologies. In this article, we describe how to properly design a lipidomic experiment in clinical research, how to handle plasma and serum samples for this purpose, and how to measure sphingolipids using liquid chromatography-mass spectrometry.

References

Merrill Jr A . Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem Rev. 2011; 111(10):6387-422. PMC: 3191729. DOI: 10.1021/cr2002917. View

Santos T, Dingjan T, Futerman A . The sphingolipid anteome: implications for evolution of the sphingolipid metabolic pathway. FEBS Lett. 2022; 596(18):2345-2363. DOI: 10.1002/1873-3468.14457. View

Lahiri S, Futerman A . The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci. 2007; 64(17):2270-84. PMC: 11136246. DOI: 10.1007/s00018-007-7076-0. View

Muralidharan S, Shimobayashi M, Ji S, Burla B, Hall M, Wenk M . A reference map of sphingolipids in murine tissues. Cell Rep. 2021; 35(11):109250. DOI: 10.1016/j.celrep.2021.109250. View

Khavandgar Z, Murshed M . Sphingolipid metabolism and its role in the skeletal tissues. Cell Mol Life Sci. 2014; 72(5):959-69. PMC: 11114007. DOI: 10.1007/s00018-014-1778-x. View

Colombaioni L, Garcia-Gil M . Sphingolipid metabolites in neural signalling and function. Brain Res Brain Res Rev. 2004; 46(3):328-55. DOI: 10.1016/j.brainresrev.2004.07.014. View

Boslem E, Meikle P, Biden T . Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction. Islets. 2012; 4(3):177-87. PMC: 3442815. DOI: 10.4161/isl.20102. View

Iqbal J, Walsh M, Hammad S, Hussain M . Sphingolipids and Lipoproteins in Health and Metabolic Disorders. Trends Endocrinol Metab. 2017; 28(7):506-518. PMC: 5474131. DOI: 10.1016/j.tem.2017.03.005. View

Dunn T, Tifft C, Proia R . A perilous path: the inborn errors of sphingolipid metabolism. J Lipid Res. 2019; 60(3):475-483. PMC: 6399501. DOI: 10.1194/jlr.S091827. View

10.

Abed Rabbo M, Khodour Y, Kaguni L, Stiban J . Sphingolipid lysosomal storage diseases: from bench to bedside. Lipids Health Dis. 2021; 20(1):44. PMC: 8094529. DOI: 10.1186/s12944-021-01466-0. View

11.

Hyotylainen T, Ahonen L, Poho P, Oresic M . Lipidomics in biomedical research-practical considerations. Biochim Biophys Acta Mol Cell Biol Lipids. 2017; 1862(8):800-803. DOI: 10.1016/j.bbalip.2017.04.002. View

12.

Zhao Y, Wu S, Liu S, Zhang Y, Lin R . Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem Biol Interact. 2014; 220:181-92. DOI: 10.1016/j.cbi.2014.06.029. View

13.

Sillence D, Platt F . Storage diseases: new insights into sphingolipid functions. Trends Cell Biol. 2003; 13(4):195-203. DOI: 10.1016/s0962-8924(03)00033-3. View

14.

Aburasayn H, Al Batran R, Ussher J . Targeting ceramide metabolism in obesity. Am J Physiol Endocrinol Metab. 2016; 311(2):E423-35. DOI: 10.1152/ajpendo.00133.2016. View

15.

Fucho R, Casals N, Serra D, Herrero L . Ceramides and mitochondrial fatty acid oxidation in obesity. FASEB J. 2016; 31(4):1263-1272. DOI: 10.1096/fj.201601156R. View

16.

Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D . Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J. 2016; 37(25):1967-76. PMC: 4929378. DOI: 10.1093/eurheartj/ehw148. View

17.

Penno A, Reilly M, Houlden H, Laura M, Rentsch K, Niederkofler V . Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem. 2010; 285(15):11178-87. PMC: 2856995. DOI: 10.1074/jbc.M109.092973. View

18.

Zuellig R, Hornemann T, Othman A, Hehl A, Bode H, Guntert T . Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells. Diabetes. 2014; 63(4):1326-39. DOI: 10.2337/db13-1042. View

19.

Shayman J . Targeting Glycosphingolipid Metabolism to Treat Kidney Disease. Nephron. 2016; 134(1):37-42. PMC: 5292033. DOI: 10.1159/000444926. View

20.

Kunkel G, Maceyka M, Milstien S, Spiegel S . Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov. 2013; 12(9):688-702. PMC: 3908769. DOI: 10.1038/nrd4099. View